KZR vs LI · $53.9M cap vs P/E 24, rev $16.06B
Kezar Life Sciences Inc (KZR) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Li Auto Inc (LI) is a auto manufacturers company listed on US. It is led by Xiang Li.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
KZR currently screens at market cap $53.9M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the KZR and LI stock pages for the full models.
Not investment advice.